Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare reported strong FY2026 results with standalone revenue of ₹15,456.6 million (up 6.3% YoY) and consolidated revenue of ₹17,030.8 million (up 12.3% YoY). Consolidated Q4 revenue grew 24.2% to ₹4,599 million. Full-year consolidated PAT rose 15.3% to ₹2,815.4 million, while Q4 PAT jumped 38.3% to ₹782.2 million. The board recommended a dividend of ₹3.5 per share (35% on ₹10 face value). Statutory auditors S.R. Batliboi & Associates LLP issued an unmodified (clean) opinion. An exceptional item of ₹15.39 million was recognized due to the New Labour Codes implementation affecting employee benefit provisions. The company also completed acquisition of Prashanthi Medicare Private Limited (76% stake) in July 2025, contributing ₹191.5 million in revenues since acquisition.
Positive results with strong revenue and profit growth. Clean audit opinion and dividend declaration are shareholder-friendly. The company continues expanding through acquisitions while maintaining profitability.